WO2002062985A1 - A yeast with nk cell immunoregulatory activity as well as the preparing method and the uses thereof - Google Patents
A yeast with nk cell immunoregulatory activity as well as the preparing method and the uses thereof Download PDFInfo
- Publication number
- WO2002062985A1 WO2002062985A1 PCT/CN2001/000118 CN0100118W WO02062985A1 WO 2002062985 A1 WO2002062985 A1 WO 2002062985A1 CN 0100118 W CN0100118 W CN 0100118W WO 02062985 A1 WO02062985 A1 WO 02062985A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- yeast
- genes
- cell
- specific
- regulate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
- A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2001/000118 WO2002062985A1 (en) | 2001-02-08 | 2001-02-08 | A yeast with nk cell immunoregulatory activity as well as the preparing method and the uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2001/000118 WO2002062985A1 (en) | 2001-02-08 | 2001-02-08 | A yeast with nk cell immunoregulatory activity as well as the preparing method and the uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002062985A1 true WO2002062985A1 (en) | 2002-08-15 |
Family
ID=4574772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2001/000118 WO2002062985A1 (en) | 2001-02-08 | 2001-02-08 | A yeast with nk cell immunoregulatory activity as well as the preparing method and the uses thereof |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2002062985A1 (en) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1375652A3 (en) * | 2002-06-28 | 2004-01-07 | Ultra Biotech Limited | Oral compositions for HIV-Infected Subjects |
EP1375651A3 (en) * | 2002-06-28 | 2004-01-07 | Ultra Biotech Limited | Oral compositions for white blood cell activation and proliferation |
US6984508B2 (en) | 2003-06-11 | 2006-01-10 | Ultra Biotech Limited | Biological compositions and methods for treatment of cervical cancer |
US6984507B2 (en) | 2003-06-11 | 2006-01-10 | Ultra Biotech Limited | Biological compositions and methods for treatment of lung cancer |
US6987012B2 (en) | 2003-06-11 | 2006-01-17 | Ultra Biotech Limited | Biological compositions and methods for treatment of colorectal cancer |
US6989253B2 (en) | 2003-06-11 | 2006-01-24 | Ultra Biotech Limited | Biological compositions and methods for treatment of testicular cancer |
US7201906B2 (en) | 2003-06-11 | 2007-04-10 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7204986B2 (en) | 2003-06-11 | 2007-04-17 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7204988B2 (en) | 2003-06-11 | 2007-04-17 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7204987B2 (en) | 2003-06-11 | 2007-04-17 | Ultra Biotech Limited | Biological compositions and methods for treatment of prostate cancer |
US7208158B2 (en) | 2003-06-11 | 2007-04-24 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7214377B2 (en) | 2003-06-11 | 2007-05-08 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7220416B2 (en) | 2003-06-11 | 2007-05-22 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223401B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223404B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223403B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223405B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepareompositions comprising yeast treated with electromagnetic energy |
US7223402B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223400B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7226600B2 (en) | 2003-06-11 | 2007-06-05 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8402388A (en) * | 1983-08-01 | 1985-03-01 | Shigezo Udaka | MEDICINAL PRODUCT SPF-100 AND METHOD FOR PREPARING THE SAME |
SU1174475A1 (en) * | 1984-02-10 | 1985-08-23 | Предприятие П/Я А-1067 | Method of processing brewer's yeast |
SU1592328A1 (en) * | 1988-05-16 | 1990-09-15 | Ki T I Pishchevoj Promy | Method of activating bakery yeasts |
EP0615757A1 (en) * | 1993-03-18 | 1994-09-21 | Georges Serge Grimberg | New therapeutic composition having an immunostimulant effect |
-
2001
- 2001-02-08 WO PCT/CN2001/000118 patent/WO2002062985A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8402388A (en) * | 1983-08-01 | 1985-03-01 | Shigezo Udaka | MEDICINAL PRODUCT SPF-100 AND METHOD FOR PREPARING THE SAME |
SU1174475A1 (en) * | 1984-02-10 | 1985-08-23 | Предприятие П/Я А-1067 | Method of processing brewer's yeast |
SU1592328A1 (en) * | 1988-05-16 | 1990-09-15 | Ki T I Pishchevoj Promy | Method of activating bakery yeasts |
EP0615757A1 (en) * | 1993-03-18 | 1994-09-21 | Georges Serge Grimberg | New therapeutic composition having an immunostimulant effect |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1375652A3 (en) * | 2002-06-28 | 2004-01-07 | Ultra Biotech Limited | Oral compositions for HIV-Infected Subjects |
EP1375651A3 (en) * | 2002-06-28 | 2004-01-07 | Ultra Biotech Limited | Oral compositions for white blood cell activation and proliferation |
US6984508B2 (en) | 2003-06-11 | 2006-01-10 | Ultra Biotech Limited | Biological compositions and methods for treatment of cervical cancer |
US6984507B2 (en) | 2003-06-11 | 2006-01-10 | Ultra Biotech Limited | Biological compositions and methods for treatment of lung cancer |
US6987012B2 (en) | 2003-06-11 | 2006-01-17 | Ultra Biotech Limited | Biological compositions and methods for treatment of colorectal cancer |
US6989253B2 (en) | 2003-06-11 | 2006-01-24 | Ultra Biotech Limited | Biological compositions and methods for treatment of testicular cancer |
US7201906B2 (en) | 2003-06-11 | 2007-04-10 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7204986B2 (en) | 2003-06-11 | 2007-04-17 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7204988B2 (en) | 2003-06-11 | 2007-04-17 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7204987B2 (en) | 2003-06-11 | 2007-04-17 | Ultra Biotech Limited | Biological compositions and methods for treatment of prostate cancer |
US7208158B2 (en) | 2003-06-11 | 2007-04-24 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7214377B2 (en) | 2003-06-11 | 2007-05-08 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7220416B2 (en) | 2003-06-11 | 2007-05-22 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223401B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223404B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223403B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223405B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepareompositions comprising yeast treated with electromagnetic energy |
US7223402B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223400B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7226600B2 (en) | 2003-06-11 | 2007-06-05 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002062983A1 (en) | A yeast with t cell immunoregulatory activity as well as the preparing method and the uses thereof | |
WO2002062985A1 (en) | A yeast with nk cell immunoregulatory activity as well as the preparing method and the uses thereof | |
WO2002062981A1 (en) | A yeast human immunoregulator and the method for preparing it | |
Chen et al. | Arsenic: a global environmental challenge | |
WO2002062984A1 (en) | The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof | |
Guan et al. | Aflatoxin B1 degradation by Stenotrophomonas maltophilia and other microbes selected using coumarin medium | |
Li et al. | A novel lectin with potent antitumor, mitogenic and HIV-1 reverse transcriptase inhibitory activities from the edible mushroom Pleurotus citrinopileatus | |
WO2002062982A1 (en) | A yeast having b cell immune regulation activity and its preparation method and application thereof | |
WO2003078431A8 (en) | Aza-bicyclic n-biarylamides with affinity for the alpha-7 nicotinic acetylcholine receptor | |
EP1375651A3 (en) | Oral compositions for white blood cell activation and proliferation | |
WO2001092308A3 (en) | Cystine-knot polypeptides: cloaked-2 molecules and uses thereof | |
WO2004016733A3 (en) | Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer | |
Lai et al. | The marine Catenovulum agarivorans MNH15 and dextranase: removing dental plaque | |
WO2007118790A3 (en) | Active potassium channel transporters (akt) and their use to create stress tolerant plants | |
Conradi et al. | The role of the cyanobacterial type IV pilus machinery in finding and maintaining a favourable environment | |
TW200734638A (en) | Method for the diagnosis of thromboembolic and coronary heart diseases | |
WO2007099348A3 (en) | Cathepsin propeptide and uses thereof | |
Jang et al. | Antidiabetic, anticholesterol, and antioxidant activity of Gryllus bimaculatus fermented by Bacillus and Lactobacillus strains | |
WO2003025010A3 (en) | Human delta-n p73 molecules and uses thereof | |
EP2116616A3 (en) | Genes differentially expressed in activated T cells and uses thereof | |
WO2006013010A3 (en) | Preparation of organisms with faster growth and/or higher yield | |
Duarte Neto et al. | Optimization of Penicillium aurantiogriseum protease immobilization on magnetic nanoparticles for antioxidant peptides’ obtainment | |
EP1849859A4 (en) | Novel polyester plastic-degrading microorganism, polyester plastic-degrading enzyme and polynucleotide encoding the enzyme | |
WO2004009781A3 (en) | Process for regulating gene expression | |
Cappello et al. | Identification and Selection of Prospective Probiotics for Enhancing Gastrointestinal Digestion: Application in Pharmaceutical Preparations and Dietary Supplements |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |